Unraveling the Impact of KRAS Accessory Proteins on Oncogenic Signaling Pathways
The oncogene KRAS drives tumor growth by activating pathways such as MAPK and PI3K-AKT in a constitutive manner. Although direct KRAS inhibitors exist, they are often limited in clinical use due to therapeutic resistance and toxicity. Therefore, alternative combinatorial therapeutic strategies are u...
Na minha lista:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI AG
2026-01-01
|
| Serier: | Cells |
| Fag: | |
| Online adgang: | https://www.mdpi.com/2073-4409/15/2/190 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
